ERBB2 and neoplasm: In contrast to large intact antibodies, other candidates with small size, including antibody fragments, affibodies, and peptides, have shorter circulation times, deeper tumor penetration, and are suitable for radiolabeling with short half-life radionuclides, making them superior to conventional antibodies in the establishment of HER2-targeted probes for molecular imaging.